Back to Wells Fargo & Company Wells Fargo & Company

PDSBPDSB

Showing 8 of 27 quarters

Position history for Wells Fargo & CompanyWells Fargo & Company's holdings in PDS Biotechnology Corporation

Yes. Wells Fargo holds 109,000 shares of PDSB (PDS Biotechnology), worth $96,040, as of its Q2 2026 13F filing. It reduced the position by 1,500 shares (-1.4%) from Q1 2026. Wells Fargo has held PDSB since Q4 2019, across 27 quarterly 13F filings.

Current Value

$96,040

Current Shares

109,000

Total Value Change

+$77,975

Total Shares Change

+104,271

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
109,000
-1.4%
$96,0400.0%$0.88
0
2026-Q1
Increased
110,500
+1973.6%
$66,8530.0%$0.61
23
2025-Q4
Unchanged
5,329
0.0%
$4,1020.0%$0.77
0
2025-Q3
Unchanged
5,329
0.0%
$5,3820.0%$1.01
0
2025-Q2
Unchanged
5,329
0.0%
$7,0880.0%$1.33
0
2025-Q1
Increased
5,329
+10.3%
$6,3420.0%$1.19
12
2024-Q4
Increased
4,829
+2.1%
$7,8710.0%$1.63
11
2024-Q3
Increased
4,729
+35.1%
$18,0650.0%$3.82
16

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used